NBI Biosciences is a revolutionary company working with plant actives to produce game changing new therapeutic medicines for chronic and other diseases. It is driven by its vision of efficacy, safety and ease of use for therapies of major chronic diseases, including diabetes, cardiovascular diseases, and neurodegeneration, merging nature’s power with scientific innovation.

The global biodiversity is our platform for opportunities which craft a stable and exciting future for design and delivery of therapeutic medicine. Plant actives unlock nature’s healing potential, and our agriculture consultants pay heed to all aspects such as sustainable harvesting, obtaining quality plants, strong testing protocols for consistent quality and a vision that delivers medicine to world populations. Most long chain molecules in plants inherently have reduced or NO side effects.

NBI’s work on new medicines has been recognized as game changing in many global markets by independent agencies. This confirms the groundbreaking ideas from the R&D team at NBI, such as, moving insulin from an injectable to an oral pill. Our other products include a formulation to lower cholesterol and reduce arterial plaques. And for a condition like Parkinson’s, we are designing new medicine that works across multiple pathways with synergistic effect. NBI regularly tests for quality and any interaction between different ingredients in the design of its formulations.

At NBI Biosciences, we are transforming plant actives for the benefit of billions of people across the world with tested, proven, safe medications.